287 A phase Ib study of pertuzumab (P), a recombinant humanized antibody to HER2, and capecitabine (C) in patients with advanced solid tumors
J.W. Valle, C. Montagut, L.C. Pronk, E.T. Jones, M. Tosca, J. Beech, B. Taylor, G. Zugmaier, P. Gascon, J. AlbanellVolume:
2
Année:
2004
Langue:
english
DOI:
10.1016/s1359-6349(04)80295-7
Fichier:
PDF, 142 KB
english, 2004